⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for central nervous system neoplasm

Every month we try and update this database with for central nervous system neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsNCT02867592
Adrenal Cortica...
Alveolar Soft P...
Central Nervous...
Childhood Clear...
Clear Cell Sarc...
Ewing Sarcoma
Hepatoblastoma
Hepatocellular ...
Osteosarcoma
Recurrent Adren...
Recurrent Alveo...
Recurrent Clear...
Recurrent Ewing...
Recurrent Hepat...
Recurrent Hepat...
Recurrent Kidne...
Recurrent Malig...
Recurrent Osteo...
Recurrent Prima...
Recurrent Renal...
Recurrent Rhabd...
Recurrent Soft ...
Recurrent Thyro...
Refractory Adre...
Refractory Alve...
Refractory Clea...
Refractory Ewin...
Refractory Hepa...
Refractory Hepa...
Refractory Mali...
Refractory Oste...
Refractory Prim...
Refractory Prim...
Refractory Rena...
Refractory Rhab...
Refractory Soft...
Refractory Thyr...
Refractory Wilm...
Renal Cell Carc...
Rhabdomyosarcom...
Soft Tissue Sar...
Solid Neoplasm
Thyroid Gland M...
Wilms Tumor
Cabozantinib
Cabozantinib S-...
Pharmacological...
2 Years - 30 YearsNational Cancer Institute (NCI)
An Investigational Scan (7T MRI) for the Imaging of Central Nervous System TumorsNCT04539574
Central Nervous...
Glioma
Metastatic Mali...
Metastatic Mali...
7 Tesla Magneti...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemNCT03270059
Central Nervous...
Cranial Nerve D...
Metastatic Mali...
Ferumoxytol
Gadolinium
Magnetic Resona...
10 Years - OHSU Knight Cancer Institute
Project: Every Child for Younger Patients With CancerNCT02402244
Carcinoma In Si...
Central Nervous...
Childhood Immat...
Childhood Lange...
Childhood Matur...
Congenital Meso...
Desmoid Fibroma...
Ganglioneuroma
Lymphoprolifera...
Malignant Solid...
Melanocytic Neo...
Myeloproliferat...
Neuroendocrine ...
Stromal Neoplas...
Cytology Specim...
Medical Chart R...
- 25 YearsChildren's Oncology Group
Project: Every Child for Younger Patients With CancerNCT02402244
Carcinoma In Si...
Central Nervous...
Childhood Immat...
Childhood Lange...
Childhood Matur...
Congenital Meso...
Desmoid Fibroma...
Ganglioneuroma
Lymphoprolifera...
Malignant Solid...
Melanocytic Neo...
Myeloproliferat...
Neuroendocrine ...
Stromal Neoplas...
Cytology Specim...
Medical Chart R...
- 25 YearsChildren's Oncology Group
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System TumorsNCT01941758
Central Nervous...
trivalent influ...
laboratory biom...
18 Years - Wake Forest University Health Sciences
Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA StudyNCT05169151
Central Nervous...
Hodgkin Lymphom...
Malignant Solid...
Non-Hodgkin Lym...
Sarcoma
Smartphone Appl...
15 Years - 39 YearsM.D. Anderson Cancer Center
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute LeukemiaNCT03834961
Central Nervous...
Infantile Fibro...
Recurrent Acute...
Refractory Acut...
Solid Neoplasm
Larotrectinib S...
- 30 YearsChildren's Oncology Group
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System TumorsNCT01941758
Central Nervous...
trivalent influ...
laboratory biom...
18 Years - Wake Forest University Health Sciences
Blood Brain Barrier Differences in Patients With Brain Tumors Undergoing SurgeryNCT03071913
Central Nervous...
Localized Brain...
Metastatic Mali...
Recurrent Brain...
Biospecimen Col...
Laboratory Biom...
18 Years - Mayo Clinic
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal TumorsNCT01217437
Central Nervous...
Pineoblastoma
Recurrent Medul...
Recurrent Primi...
Refractory Medu...
Refractory Peri...
Bevacizumab
Irinotecan Hydr...
Temozolomide
- 21 YearsNational Cancer Institute (NCI)
An Investigational Scan (7T MRI) for the Imaging of Central Nervous System TumorsNCT04539574
Central Nervous...
Glioma
Metastatic Mali...
Metastatic Mali...
7 Tesla Magneti...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-OncologyNCT04988009
Central Nervous...
Leptomeningeal ...
Metastatic Mali...
Primary Brain N...
Electronic Heal...
Survey Administ...
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: